COVID-19 vaccine doses administered in India November 2023
- ai-chatbox.pro
- statista.com
Updated Dec 19, 2023
Share
Facebook
Twitter
EmailClick to copy linkLink copiedCiteStatista Research Department (2023). COVID-19 vaccine doses administered in India November 2023 [Dataset]. https://www.ai-chatbox.pro/?_=%2Ftopics%2F6135%2Fcoronavirus-covid-19-outbreak-in-india%2F%23XgboD02vawLbpWJjSPEePEUG%2FVFd%2Bik%3DDataset updatedDec 19, 2023AuthorsStatista Research DepartmentArea coveredIndiaDescriptionThe Indian state of Utter Pradesh reported the highest number of administered doses of the vaccine against the coronavirus (COVID-19) as of November 13, 2023. Furthermore, over 2.2 billion total vaccine doses were administered in India during the same time period.
Vaccination in India were administered since January 16, 2021, with the administration of vaccines to all health care workers in the first phase. In February, the vaccination program was expanded to cover front line workers. The second phase of the program began in March which included citizens above the age of 60 and subsequently, people above the age of 45 with comorbidities. India’s vaccination program currently includes two vaccines, namely, Oxford University – AstraZeneca’s Covidshield vaccine, manufactured by the Serum Institute of India and Bharat Biotech Covaxin. Russia's Sputnik V was expected to be added to the mix starting May 2021.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
FacebookTwitterEmailThe Indian state of Utter Pradesh reported the highest number of administered doses of the vaccine against the coronavirus (COVID-19) as of November 13, 2023. Furthermore, over 2.2 billion total vaccine doses were administered in India during the same time period.
Vaccination in India were administered since January 16, 2021, with the administration of vaccines to all health care workers in the first phase. In February, the vaccination program was expanded to cover front line workers. The second phase of the program began in March which included citizens above the age of 60 and subsequently, people above the age of 45 with comorbidities. India’s vaccination program currently includes two vaccines, namely, Oxford University – AstraZeneca’s Covidshield vaccine, manufactured by the Serum Institute of India and Bharat Biotech Covaxin. Russia's Sputnik V was expected to be added to the mix starting May 2021.